Crowd-Powered Microvascular Modeling
About the Research Project
Program
Award Type
Other
Award Amount
$421,000
Active Dates
January 01, 2016 - June 30, 2017
Grant ID
CA2016629
Summary
Cornell University researchers have made breakthrough discoveries in understanding the role of brain blood flow in Alzheimer’s disease (AD), but more evidence is needed to establish whether freeing stalled capillaries might results in a possible treatment approach. The problem is that it takes an entire year to analyze the data needed to answer each research question, and progress to date has been very slow. “Stall Catchers” is a citizen science research project developed by the Human Computation Institute in collaboration with Cornell investigators Chris Schaffer and Nozomi Nishimura aimed at speeding up Cornell’s data analysis by turning it into an online game that anyone can play. Our Phase I goal is to see whether thousands of public participants can analyze the research data just as accurately as lab experts, but by working together, do it much faster. In Phase II, we will apply the validated crowd engine to new experimental data to see if we can reduce the time to a treatment target from decades to just a few years. This is the first citizen science project supporting Alzheimer’s disease (AD) research. To learn more about EyesOnAlz, visit www.eyesonalz.com.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD